871 related articles for article (PubMed ID: 16197418)
1. Prurigo nodularis: a review.
Lee MR; Shumack S
Australas J Dermatol; 2005 Nov; 46(4):211-18; quiz 219-20. PubMed ID: 16197418
[TBL] [Abstract][Full Text] [Related]
2. Treatment of prurigo nodularis with topical capsaicin.
Ständer S; Luger T; Metze D
J Am Acad Dermatol; 2001 Mar; 44(3):471-8. PubMed ID: 11209117
[TBL] [Abstract][Full Text] [Related]
3. Prurigo Nodularis and Its Management.
Zeidler C; Yosipovitch G; Ständer S
Dermatol Clin; 2018 Jul; 36(3):189-197. PubMed ID: 29929592
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of evidence-based treatments for prurigo nodularis.
Qureshi AA; Abate LE; Yosipovitch G; Friedman AJ
J Am Acad Dermatol; 2019 Mar; 80(3):756-764. PubMed ID: 30261199
[TBL] [Abstract][Full Text] [Related]
5. Increased nerve growth factor- and tyrosine kinase A-like immunoreactivities in prurigo nodularis skin -- an exploration of the cause of neurohyperplasia.
Johansson O; Liang Y; Emtestam L
Arch Dermatol Res; 2002 Feb; 293(12):614-9. PubMed ID: 11875644
[TBL] [Abstract][Full Text] [Related]
6. Antipruritic effect of cyclosporine microemulsion in prurigo nodularis: results of a case series.
Siepmann D; Luger TA; Ständer S
J Dtsch Dermatol Ges; 2008 Nov; 6(11):941-6. PubMed ID: 18445069
[TBL] [Abstract][Full Text] [Related]
7. Prurigo nodularis of Hyde treated with low-dose thalidomide.
Orlando A; Renna S; Cottone M
Eur Rev Med Pharmacol Sci; 2009; 13(2):141-5. PubMed ID: 19499850
[TBL] [Abstract][Full Text] [Related]
8. Prurigo Nodularis Management.
Tsianakas A; Zeidler C; Ständer S
Curr Probl Dermatol; 2016; 50():94-101. PubMed ID: 27578077
[TBL] [Abstract][Full Text] [Related]
9. Prurigo nodularis: Pathogenesis and management.
Williams KA; Huang AH; Belzberg M; Kwatra SG
J Am Acad Dermatol; 2020 Dec; 83(6):1567-1575. PubMed ID: 32461078
[TBL] [Abstract][Full Text] [Related]
10. Topical vitamin D3 (tacalcitol) for steroid-resistant prurigo.
Katayama I; Miyazaki Y; Nishioka K
Br J Dermatol; 1996 Aug; 135(2):237-40. PubMed ID: 8881666
[TBL] [Abstract][Full Text] [Related]
11. Chronic Prurigo of Nodular Type: A Review.
Zeidler C; Tsianakas A; Pereira M; Ständer H; Yosipovitch G; Ständer S
Acta Derm Venereol; 2018 Feb; 98(2):173-179. PubMed ID: 29135018
[TBL] [Abstract][Full Text] [Related]
12. Thalidomide treatment for prurigo nodularis in human immunodeficiency virus-infected subjects: efficacy and risk of neuropathy.
Maurer T; Poncelet A; Berger T
Arch Dermatol; 2004 Jul; 140(7):845-9. PubMed ID: 15262695
[TBL] [Abstract][Full Text] [Related]
13. Use of lenalidomide in treating refractory prurigo nodularis.
Liu H; Gaspari AA; Schleichert R
J Drugs Dermatol; 2013 Mar; 12(3):360-1. PubMed ID: 23545923
[TBL] [Abstract][Full Text] [Related]
14. Thalidomide for the treatment of chronic refractory prurigo nodularis.
Aguh C; Kwatra SG; He A; Okoye GA
Dermatol Online J; 2018 Mar; 24(3):. PubMed ID: 29634881
[TBL] [Abstract][Full Text] [Related]
15. Treatment of prurigo nodularis with lenalidomide.
Ossorio-García L; Jiménez-Gallo D; Rodríguez-Mateos ME; Arjona-Aguilera C; Linares-Barrios M
Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 27891738
[TBL] [Abstract][Full Text] [Related]
16. Thalidomide in 42 patients with prurigo nodularis Hyde.
Andersen TP; Fogh K
Dermatology; 2011; 223(2):107-12. PubMed ID: 21952556
[TBL] [Abstract][Full Text] [Related]
17. Dermatologic and nondermatologic uses of thalidomide.
Nasca MR; Micali G; Cheigh NH; West LE; West DP
Ann Pharmacother; 2003 Sep; 37(9):1307-20. PubMed ID: 12921515
[TBL] [Abstract][Full Text] [Related]
18. Prurigo nodularis: a benign dermatosis derived from a persistent pruritus.
Vaidya DC; Schwartz RA
Acta Dermatovenerol Croat; 2008; 16(1):38-44. PubMed ID: 18358109
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of thalidomide in the treatment of prurigo nodularis.
Taefehnorooz H; Truchetet F; Barbaud A; Schmutz JL; Bursztejn AC
Acta Derm Venereol; 2011 May; 91(3):344-5. PubMed ID: 21279302
[No Abstract] [Full Text] [Related]
20. Intractable prurigo nodularis successfully treated with combination therapy with a newly developed excimer laser and topical steroids.
Nakashima C; Tanizaki H; Otsuka A; Miyachi Y; Kabashima K
Dermatol Online J; 2014 Jun; 20(6):. PubMed ID: 24945654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
